Startups
Edit
Modis Therapeutics (A Zogenix Company)
https://www.modistx.com/Last activity: 26.08.2019
Probably Closed
Modis Therapeutics is a biopharmaceutical company focused on developing therapies for rare genetic diseases with high unmet medical need.
Overview
Location
United States, California, Emeryville
Employees
51-200
Total raised
$30M
Founded date
2016
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 26, 2019 | Zogenix pays $250M upfront for startup Modis and its FDA 'breakthrough' med W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | As fairy-tale biotech stories go, this is up there: You’re a small, ambitious startup getting a healthy $30 million series A round. Fast-forward less than a year, and you’re being bought for a quarter of billion dollars upfront. Sponsored b... |
| Aug 26, 2019 | Zogenix pays $250M upfront for startup Modis and its FDA 'breakthrough' med | As fairy-tale biotech stories go, this is up there: You’re a small, ambitious startup getting a healthy $30 million series A round. Fast-forward less than a year, and you’re being bought for a quarter of billion dollars upfront. That’s the ... |
| Oct 14, 2018 | F-Prime Capital Leads $30M Series A for Modis Therapeutics | Modis Therapeutics, Inc., a company developing medicines for patients with rare genetic diseases, announced today a $30M Series A investment led by F-Prime Capital Partners and OrbiMed. Joshua Grass, former F-Prime Entrepreneur-in-Residence... |
| Oct 1, 2018 | Modis Therapeutics Raises $30M in Series A Funding | Modis Therapeutics, an Oakland, CA-based company developing medicines for patients with rare genetic diseases, raised $30M in Series A funding. The round was led by F-Prime Capital Partners and OrbiMed. Founding investor Aceras Life Science... |
Reviews 0
FAQ about Modis Therapeutics (A Zogenix Company)
When was Modis Therapeutics (A Zogenix Company) founded?
Modis Therapeutics (A Zogenix Company) was founded in 2016.
How much funding has Modis Therapeutics (A Zogenix Company) raised?
Modis Therapeutics (A Zogenix Company) has raised $30M in total across 1 funding round.
What has the press written about Modis Therapeutics (A Zogenix Company)?
Parsers VC has collected 5 articles mentioning Modis Therapeutics (A Zogenix Company), among them “Zogenix pays $250M upfront for startup Modis and its FDA 'breakthrough' med W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compli...” (Aug 26, 2019) and “Zogenix pays $250M upfront for startup Modis and its FDA 'breakthrough' med” (Aug 26, 2019).
Is Modis Therapeutics (A Zogenix Company) still active?
Modis Therapeutics (A Zogenix Company) is probably closed: its latest activity on Parsers VC dates from Aug 26, 2019.